Launch Readiness March 21, 2023 Perspectives on Pharma Market Access Launch Challenges & Strategy Part 2 9 Minute Read We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
Launch Readiness February 7, 2023 Perspectives on Pharma Market Access Launch Challenges & Strategy Part 1 5 Minute Read We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
Launch Readiness June 7, 2022 Best Practices: Identifying and Avoiding Patient Access Barriers 4 Minute Read Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.
Launch Readiness March 24, 2022 Best Practices: Achieving Your Pre-Launch Sales Forecasts 6 Minute Read Market access leaders from DBV Technologies, Karyopharm Therapeutics, and Sesen Bio discuss critical factors in a successful launch and ways to achieve pre-launch forecasts.
Launch Readiness January 19, 2022 Best Practices: Redesigning the Perfect Launch 3 Minute Read We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
Gross-to-Net January 28, 2021 Five Steps to GTN Implementation Success 3 Minute Read Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices.
Gross-to-Net December 10, 2020 Gross-to-Net Roadmap to Launch 3 Minute Read A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product.
